Arabic Arabic English English French French German German
dark

MolecuLight Receives Innovative Technology Contract from Vizient for its i:X® Fluorescence Wound Imaging Device

MolecuLight Corp., the leader in point-of-care fluorescence imaging for detection of wounds containing elevated bacterial loads, announces its MolecuLight i:X® fluorescence wound imaging device has received an Innovative Technology contract from Vizient, Inc., the nations’ largest member-driven health care performance improvement company. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Biorasi Welcomes Hematologist Dr. Robert S. Negrin to Scientific Advisory Board

Next Post

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

Related Posts
Total
0
Share